Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

883 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients.
van Leeuwen R, Katlama C, Murphy RL, Squires K, Gatell J, Horban A, Clotet B, Staszewski S, van Eeden A, Clumeck N, Moroni M, Pavia AT, Schmidt RE, Gonzalez-Lahoz J, Montaner J, Antunes F, Gulick R, Bánhegyi D, van der Valk M, Reiss P, van Weert L, van Leth F, Johnson VA, Sommadossi JP, Lange JM. van Leeuwen R, et al. Among authors: reiss p. AIDS. 2003 May 2;17(7):987-99. doi: 10.1097/00002030-200305020-00007. AIDS. 2003. PMID: 12700448 Clinical Trial.
Lipid profiles associated with antiretroviral drug choices.
van der Valk M, Reiss P. van der Valk M, et al. Among authors: reiss p. Curr Opin Infect Dis. 2003 Feb;16(1):19-23. doi: 10.1097/00001432-200302000-00004. Curr Opin Infect Dis. 2003. PMID: 12821825 Review.
Impact of nevirapine on lipid metabolism.
Clotet B, van der Valk M, Negredo E, Reiss P. Clotet B, et al. Among authors: reiss p. J Acquir Immune Defic Syndr. 2003 Sep;34 Suppl 1:S79-84. doi: 10.1097/00126334-200309011-00012. J Acquir Immune Defic Syndr. 2003. PMID: 14562862 Review.
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes.
Ledergerber B, Lundgren JD, Walker AS, Sabin C, Justice A, Reiss P, Mussini C, Wit F, d'Arminio Monforte A, Weber R, Fusco G, Staszewski S, Law M, Hogg R, Lampe F, Gill MJ, Castelli F, Phillips AN; PLATO Collaboration. Ledergerber B, et al. Among authors: reiss p. Lancet. 2004 Jul 3-9;364(9428):51-62. doi: 10.1016/S0140-6736(04)16589-6. Lancet. 2004. PMID: 15234856
Markedly diminished lipolysis and partial restoration of glucose metabolism, without changes in fat distribution after extended discontinuation of protease inhibitors in severe lipodystrophic human immunodeficient virus-1-infected patients.
van der Valk M, Allick G, Weverling GJ, Romijn JA, Ackermans MT, Lange JM, van Eck-Smit BL, van Kuijk C, Endert E, Sauerwein HP, Reiss P. van der Valk M, et al. Among authors: reiss p. J Clin Endocrinol Metab. 2004 Jul;89(7):3554-60. doi: 10.1210/jc.2003-030985. J Clin Endocrinol Metab. 2004. PMID: 15240645 Clinical Trial.
Prevalence of lipoatrophy and mitochondrial DNA content of blood and subcutaneous fat in HIV-1-infected patients randomly allocated to zidovudine- or stavudine-based therapy.
van der Valk M, Casula M, Weverlingz GJ, van Kuijk K, van Eck-Smit B, Hulsebosch HJ, Nieuwkerk P, van Eeden A, Brinkman K, Lange J, de Ronde A, Reiss P. van der Valk M, et al. Among authors: reiss p. Antivir Ther. 2004 Jun;9(3):385-93. Antivir Ther. 2004. PMID: 15259901 Clinical Trial.
883 results